{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:42:35Z","timestamp":1788878555382,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"],"award-info":[{"award-number":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"],"award-info":[{"award-number":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"],"award-info":[{"award-number":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"],"award-info":[{"award-number":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"],"award-info":[{"award-number":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"],"award-info":[{"award-number":["219692\/Z\/19\/Z & 226432\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["845681"],"award-info":[{"award-number":["845681"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["845681"],"award-info":[{"award-number":["845681"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Salmonella enterica<\/jats:italic>\n                      subspecies\n                      <jats:italic>enterica<\/jats:italic>\n                      serovar Typhi (abbreviated as \u2018Typhi\u2019) is the bacterial agent of typhoid fever. Effective antimicrobial therapy reduces complications and mortality; however, antimicrobial resistance (AMR) is a major problem in many endemic countries. Prevention through vaccination is possible through recently-licensed typhoid conjugate vaccines (TCVs). National immunisation programs are currently being considered or deployed in several countries where AMR prevalence is known to be high, and the Gavi vaccine alliance has provided financial support for their introduction. Pathogen whole genome sequence data are a rich source of information on Typhi variants (genotypes or lineages), AMR prevalence, and mechanisms. However, this information is currently not readily accessible to non-genomics experts, including those driving vaccine implementation or empirical therapy guidance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We developed TyphiNET (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.typhi.net\" ext-link-type=\"uri\">https:\/\/www.typhi.net<\/jats:ext-link>\n                      ), an interactive online dashboard for exploring Typhi genotype and AMR distributions derived from publicly available pathogen genome sequences. TyphiNET allows users to explore country-level summaries such as the frequency of pathogen lineages, temporal trends in resistance to clinically relevant antimicrobials, and the specific variants and mechanisms underlying emergent AMR trends. User-driven plots and session reports can be downloaded for ease of sharing. Importantly, TyphiNET is populated by high-quality genome data curated by the Global Typhoid Pathogen Genomics Consortium, analysed using the Pathogenwatch platform, and identified as coming from non-targeted sampling frames that are suitable for estimating AMR prevalence amongst Typhi infections (no personal data is included in the platform). As of February 2024, data from a total of\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911,836 genomes from 101 countries are available in TyphiNET. We outline case studies illustrating how the dashboard can be used to explore these data and gain insights of relevance to both researchers and public health policy-makers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The TyphiNET dashboard provides an interactive platform for accessing genome-derived data on pathogen variant frequencies to inform typhoid control and intervention strategies. The platform is extensible in terms of both data and features, and provides a model for making complex bacterial genome-derived data accessible to a wide audience.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-025-01470-4","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:13:26Z","timestamp":1746764006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health"],"prefix":"10.1186","volume":"17","author":[{"given":"Zoe A.","family":"Dyson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Cerdeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Global Typhoid Genomics Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Aanensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine Abou","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayorinde O.","family":"Afolayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irshad","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afreenish","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadia","family":"Andleeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Argim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel K.","family":"Aworh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish R.","family":"Bavdekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.","family":"Chattaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Lip","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Crump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Darton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula L.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Dolecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Feasey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Greenhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mochammad","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene S.","family":"Hendriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Heyderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odion O.","family":"Ikhimiukor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamer","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle J.","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Keddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calman A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mailis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Mahindroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapfumanei","family":"Mashe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elli","family":"Mylona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satheesh","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Take K.","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Njamkepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Octavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iruka N.","family":"Okeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pardos","family":"de la Gandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia I. A.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikt","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Rasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elrashdy M.","family":"Redwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Rokney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Rupali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Rutanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jivan","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senjuti","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Sikorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin A.","family":"Tagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipesh","family":"Tamrakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Ussher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Van Puyvelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Vandelannoote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"1470_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-023-00480-z","volume":"9","author":"JE Meiring","year":"2023","unstructured":"Meiring JE, Khanam F, Basnyat B, Charles RC, Crump JA, Debellut F, et al. Typhoid fever. Nat Rev Dis Prim. 2023;9:71.","journal-title":"Nat Rev Dis Prim"},{"key":"1470_CR2","doi-asserted-by":"crossref","unstructured":"GBD 2019 Diseases and Injuries Collaborators, Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"1470_CR3","doi-asserted-by":"crossref","unstructured":"GBD 2017 Typhoid and Paratyphoid Collaborators. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019;19:369-81.","DOI":"10.1016\/S1473-3099(18)30685-6"},{"key":"1470_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/jcp.15.6.544","volume":"15","author":"BR Murti","year":"1962","unstructured":"Murti BR, Rajyalakshmi K, Bhaskaran CS. Resistance of Salmonella Typhi to chloramphenicol. J Clin Pathol. 1962;15:544.","journal-title":"J Clin Pathol"},{"key":"1470_CR5","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1093\/cid\/ciy1111","volume":"68","author":"ZA Dyson","year":"2019","unstructured":"Dyson ZA, Klemm EJ, Palmer S, Dougan G. Antibiotic resistance and typhoid. Clin Infect Dis. 2019;68:S165\u201370.","journal-title":"Clin Infect Dis"},{"key":"1470_CR6","doi-asserted-by":"publisher","first-page":"e1163","DOI":"10.1371\/journal.pntd.0001163","volume":"5","author":"CM Parry","year":"2011","unstructured":"Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, Hien TT, et al. The Influence of Reduced Susceptibility to Fluoroquinolones in Salmonella enterica Serovar Typhi on the Clinical Response to Ofloxacin Therapy. Plos Negl Trop Dis. 2011;5:e1163.","journal-title":"Plos Negl Trop Dis"},{"key":"1470_CR7","doi-asserted-by":"publisher","first-page":"S435","DOI":"10.1093\/cid\/ciz477","volume":"69","author":"LMC Espinoza","year":"2019","unstructured":"Espinoza LMC, McCreedy E, Holm M, Im J, Mogeni OD, Parajulee P, et al. Occurrence of typhoid fever complications and their relation to duration of illness preceding hospitalization: a systematic literature review and meta-analysis. Clin Infect Dis. 2019;69:S435\u201348.","journal-title":"Clin Infect Dis"},{"key":"1470_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/clinids\/7.2.244","volume":"7","author":"T Butler","year":"1985","unstructured":"Butler T, Knight J, Nath SK, Speelman P, Roy SK, Azad MA. Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis. 1985;7:244\u201356.","journal-title":"Rev Infect Dis"},{"key":"1470_CR9","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/cid\/ciy846","volume":"68","author":"JA Crump","year":"2019","unstructured":"Crump JA. Progress in Typhoid Fever Epidemiology. Clin Infect Dis. 2019;68:S4-9.","journal-title":"Clin Infect Dis"},{"key":"1470_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3855\/jidc.164","volume":"2","author":"J Wain","year":"2008","unstructured":"Wain J, Diep TS, Bay PVB, Walsh AL, Vinh H, Duong NM, et al. Specimens and culture media for the laboratory diagnosis of typhoid fever. J Infect Dev Ctries. 2008;2:469\u201374.","journal-title":"J Infect Dev Ctries"},{"key":"1470_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12941-016-0147-z","volume":"15","author":"V Mogasale","year":"2016","unstructured":"Mogasale V, Ramani E, Mogasale VV, Park J. What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature review. Ann Clin Microbiol Antimicrob. 2016;15:32.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1470_CR12","unstructured":"World Health Organization. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. Geneva; 2022."},{"key":"1470_CR13","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S1473-3099(18)30350-5","volume":"19","author":"JR Andrews","year":"2019","unstructured":"Andrews JR, Baker S, Marks F, Alsan M, Garrett D, Gellin BG, et al. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. Lancet Infect Dis. 2019;19:e26-30.","journal-title":"Lancet Infect Dis"},{"key":"1470_CR14","unstructured":"Gavi - The Vaccine Alliance. Gavi - The Vaccine Alliance. Gavi - The Vaccine Alliance. 2024. Available from: https:\/\/www.gavi.org\/.  Cited 2025 Feb 17."},{"key":"1470_CR15","first-page":"153","volume":"13","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Typhoid vaccines: WHO position paper. Week Epidemiol Rec. 2018;13:153\u201372.","journal-title":"Week Epidemiol Rec"},{"key":"1470_CR16","doi-asserted-by":"publisher","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","volume":"9","author":"MT Yousafzai","year":"2021","unstructured":"Yousafzai MT, Karim S, Qureshi S, Kazi M, Memon H, Junejo A, et al. Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study. Lancet Glob Health. 2021;9:e1154\u201362.","journal-title":"Lancet Glob Health"},{"key":"1470_CR17","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1016\/j.vaccine.2022.04.093","volume":"40","author":"MS Lightowler","year":"2022","unstructured":"Lightowler MS, Manangazira P, Nackers F, Herp MV, Phiri I, Kuwenyi K, et al. Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study. Vaccine. 2022;40:4199\u2013210.","journal-title":"Vaccine"},{"key":"1470_CR18","unstructured":"World Health Organization. Pakistan first country to introduce new typhoid vaccine into routine immunization programme. 2019. Available from: https:\/\/www.emro.who.int\/pak\/pakistan-news\/pakistan-first-country-to-introduce-new-typhoid-vaccine-into-routine-immunization-programme.html.  Cited 2023 May 30."},{"key":"1470_CR19","unstructured":"Oberman E. Typhoid conjugate vaccine arrives in Zimbabwe. 2021. Available from: https:\/\/www.coalitionagainsttyphoid.org\/typhoid-conjugate-vaccine-arrives-in-zimbabwe\/.  Cited 2023 May 30."},{"issue":"5","key":"1470_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/jac\/dkab029","volume":"76","author":"T Mashe","year":"2021","unstructured":"Mashe T, Leekitcharoenphon P, Mtapuri-Zinyowera S, Kingsley RA, Robertson V, Tarupiwa A, et al. Salmonella enterica serovar Typhi H58 clone has been endemic in Zimbabwe from 2012 to 2019. J Antimicrob Chemother. 2021;76(5):1375.","journal-title":"J Antimicrob Chemother"},{"key":"1470_CR21","doi-asserted-by":"publisher","first-page":"e1005","DOI":"10.1016\/S2666-5247(23)00214-8","volume":"4","author":"G Thilliez","year":"2023","unstructured":"Thilliez G, Mashe T, Chaibva BV, Robertson V, Bawn M, Tarupiwa A, et al. Population structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012\u201319) before typhoid conjugate vaccine roll-out: a genomic epidemiology study. Lancet Microbe. 2023;4:e1005\u201314.","journal-title":"Lancet Microbe"},{"key":"1470_CR22","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva; 2022. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240062702"},{"key":"1470_CR23","doi-asserted-by":"publisher","first-page":"e0007620","DOI":"10.1371\/journal.pntd.0007620","volume":"13","author":"DJ Ingle","year":"2019","unstructured":"Ingle DJ, Nair S, Hartman H, Ashton PM, Dyson ZA, Day M, et al. Informal genomic surveillance of regional distribution of Salmonella Typhi genotypes and antimicrobial resistance via returning travellers. Akullian A, editor. PLoS Negl Trop Dis. 2019;13:e0007620.","journal-title":"PLoS Negl Trop Dis"},{"key":"1470_CR24","unstructured":"Carey ME, Dyson ZA, Ingle DJ, Amir A, Aworh MK, Chattaway MA, et al. Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes. eLife. 2023;12:e85867."},{"key":"1470_CR25","doi-asserted-by":"publisher","first-page":"e1752","DOI":"10.7717\/peerj.1752","volume":"4","author":"PM Ashton","year":"2016","unstructured":"Ashton PM, Nair S, Peters TM, Bale JA, Powell DG, Painset A, et al. Identification of Salmonella for public health surveillance using whole genome sequencing. PeerJ. 2016;4:e1752.","journal-title":"PeerJ"},{"key":"1470_CR26","first-page":"000633","volume":"7","author":"MA Chattaway","year":"2021","unstructured":"Chattaway MA, Gentle A, Nair S, Tingley L, Day M, Mohamed I, et al. Phylogenomics and antimicrobial resistance of Salmonella Typhi and Paratyphi A, B and C in England, 2016\u20132019. Microb Genom. 2021;7:000633.","journal-title":"Microb Genom"},{"key":"1470_CR27","doi-asserted-by":"publisher","first-page":"S775","DOI":"10.1093\/infdis\/jiab414","volume":"224","author":"ZA Dyson","year":"2021","unstructured":"Dyson ZA, Holt KE. Five Years of GenoTyphi: Updates to the Global Salmonella Typhi Genotyping Framework. J Infect Dis. 2021;224:S775\u201380.","journal-title":"J Infect Dis"},{"key":"1470_CR28","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.1038\/ncomms12827","volume":"7","author":"VK Wong","year":"2016","unstructured":"Wong VK, Baker S, Connor TR, Pickard D, Page AJ, Dave J, et al. An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid. Nat Commun. 2016;7:12827.","journal-title":"Nat Commun"},{"key":"1470_CR29","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1038\/s41467-021-23091-2","volume":"12","author":"S Argimon","year":"2021","unstructured":"Argimon S, Yeats CA, Goater RJ, Abudahab K, Taylor B, Underwood A, et al. A global resource for genomic predictions of antimicrobial resistance and surveillance of Salmonella Typhi at pathogenwatch. Nat Commun. 2021;12:2879\u2013912.","journal-title":"Nat Commun"},{"key":"1470_CR30","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/jac\/dkab049","volume":"76","author":"S Nair","year":"2021","unstructured":"Nair S, Chattaway M, Langridge GC, Gentle A, Day M, Ainsworth EV, et al. ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi. J Antimicrob Chemother. 2021;76:1459\u201366.","journal-title":"J Antimicrob Chemother"},{"key":"1470_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.15585\/mmwr.mm6920a2","volume":"69","author":"LKF Watkins","year":"2020","unstructured":"Watkins LKF, Winstead A, Appiah GD, Friedman CR, Medalla F, Hughes MJ, et al. Update on Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or from Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq \u2014 United States, 2018\u20132019. Morbidity Mortal Wkly Rep. 2020;69:618\u201322.","journal-title":"Morbidity Mortal Wkly Rep"},{"key":"1470_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2022.01.014","volume":"84","author":"LE Nabarro","year":"2022","unstructured":"Nabarro LE, McCann N, Herdman MT, Dugan C, Ladhani S, Patel D, et al. British infection association guidelines for the diagnosis and management of enteric fever in England. J Infection. 2022;84:469\u201389.","journal-title":"J Infection"},{"key":"1470_CR33","doi-asserted-by":"crossref","unstructured":"Gauld JS, Olgemoeller F, Heinz E, Nkhata R, Bilima S, Wailan AM, et al. Spatial and genomic data to characterize endemic typhoid transmission. Clin Infect Dis. 2022;74:ciab745.","DOI":"10.1093\/cid\/ciab745"},{"key":"1470_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13073-022-01020-2","volume":"14","author":"C Waddington","year":"2022","unstructured":"Waddington C, Carey ME, Boinett CJ, Higginson E, Veeraraghavan B, Baker S. Exploiting genomics to mitigate the public health impact of antimicrobial resistance. Genome Med. 2022;14:15.","journal-title":"Genome Med"},{"key":"1470_CR35","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1056\/NEJMsr1813907","volume":"381","author":"GL Armstrong","year":"2019","unstructured":"Armstrong GL, MacCannell DR, Taylor J, Carleton HA, Neuhaus EB, Bradbury RS, et al. Pathogen genomics in public health. New Engl J Med. 2019;381:2569\u201380.","journal-title":"New Engl J Med"},{"key":"1470_CR36","unstructured":"National Center for Biotechnology Information. NCBI Pathogen Detection. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pathogens\/isolates\/#taxgroup_name:%22Salmonella%20enterica%22"},{"key":"1470_CR37","doi-asserted-by":"crossref","unstructured":"Zhou Z, Alikhan N-F, Mohamed K, Fan Y, Group the AS, Achtman M, et al. The EnteroBase user\u2019s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 2020;30:138-52.38. Salmonella EnteroBase. Available from: https:\/\/enterobase.warwick.ac.uk\/species\/index\/senterica","DOI":"10.1101\/gr.251678.119"},{"key":"1470_CR38","unstructured":"Salmonella EnteroBase. Available from: https:\/\/enterobase.warwick.ac.uk\/species\/index\/senterica ."},{"key":"1470_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/1471-2105-11-595","volume":"11","author":"KA Jolley","year":"2010","unstructured":"Jolley KA, Maiden MCJ. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010;11:595.","journal-title":"BMC Bioinformatics"},{"key":"1470_CR40","doi-asserted-by":"crossref","unstructured":"Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, et al. Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins. mBio. 2018;9.","DOI":"10.1128\/mBio.00105-18"},{"key":"1470_CR41","doi-asserted-by":"publisher","first-page":"e0007868","DOI":"10.1371\/journal.pntd.0007868","volume":"13","author":"Y Hooda","year":"2019","unstructured":"Hooda Y, Sajib MSI, Rahman H, Luby SP, Bondy-Denomy J, Santosham M, et al. Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance. PLoS Negl Trop Dis. 2019;13:e0007868.","journal-title":"PLoS Negl Trop Dis"},{"key":"1470_CR42","doi-asserted-by":"publisher","unstructured":"Cerdeira L, Sousa M, Dyson Z. lcerdeira\/Spyder: Spyder. 2021; Available from: https:\/\/doi.org\/10.5281\/zenodo.14887041","DOI":"10.5281\/zenodo.14887041"},{"key":"1470_CR43","doi-asserted-by":"publisher","unstructured":"Cerdeira L, vLSHTM, Dyson ZA, Holt K. typhoidgenomics\/TyphiNET: v1.6. 2025; Available from: https:\/\/doi.org\/10.5281\/zenodo.5338903","DOI":"10.5281\/zenodo.5338903"},{"key":"1470_CR44","doi-asserted-by":"publisher","first-page":"jiab414","DOI":"10.1093\/infdis\/jiab414","volume":"224","author":"ZA Dyson","year":"2021","unstructured":"Dyson ZA, Holt KE. Five years of GenoTyphi: updates to the global Salmonella Typhi genotyping framework. J Infect Dis. 2021;224:jiab414.","journal-title":"J Infect Dis."},{"key":"1470_CR45","doi-asserted-by":"publisher","first-page":"ofx230","DOI":"10.1093\/ofid\/ofx230","volume":"4","author":"T Matono","year":"2017","unstructured":"Matono T, Morita M, Yahara K, Lee K, Izumiya H, Kaku M, et al. Emergence of Resistance Mutations in Salmonella enterica Serovar Typhi Against Fluoroquinolones. Open Forum Infect Dis. 2017;4:ofx230.","journal-title":"Open Forum Infect Dis"},{"key":"1470_CR46","doi-asserted-by":"publisher","first-page":"e01200","DOI":"10.1128\/AAC.01200-21","volume":"65","author":"DJ Ingle","year":"2021","unstructured":"Ingle DJ, Andersson P, Valcanis M, Wilmot M, Easton M, Lane C, et al. Genomic epidemiology and antimicrobial resistance mechanisms of imported typhoid in Australia. Antimicrob Agents Chemother. 2021;65:e01200-e1221.","journal-title":"Antimicrob Agents Chemother"},{"key":"1470_CR47","unstructured":"Centers for Disease Control and Prevention (CDC). National Typhoid and Paratyphoid Fever Surveillance Overview. Atlanta, Georgia: US Department of Health and Human Services, CDC; 2011. Available from: https:\/\/www.cdc.gov\/ncezid\/dfwed\/PDFs\/typhi_surveillance_overview_508c.pdf"},{"key":"1470_CR48","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1093\/ofid\/ofad055","volume":"10","author":"J Chen","year":"2023","unstructured":"Chen J, Long JE, Vannice K, Shewchuk T, Kumar S, Steele AD, et al. Taking on typhoid: eliminating typhoid fever as a global health problem. Open Forum Infect Dis. 2023;10:S74-81.","journal-title":"Open Forum Infect Dis"},{"key":"1470_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jac\/dkx379","volume":"73","author":"MR Day","year":"2018","unstructured":"Day MR, Doumith M, Nascimento VD, Nair S, Ashton PM, Jenkins C, et al. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi. J Antimicrob Chemoth. 2018;73:365\u201372.","journal-title":"J Antimicrob Chemoth"},{"key":"1470_CR50","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1128\/JCM.36.6.1683-1687.1998","volume":"36","author":"J Wain","year":"1998","unstructured":"Wain J, Diep TS, Ho VA, Walsh AM, Hoa NTT, Parry CM, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol. 1998;36:1683\u20137.","journal-title":"J Clin Microbiol"},{"key":"1470_CR51","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints - breakpoints and guidance. 2023. Available from: https:\/\/www.eucast.org\/clinical_breakpoints.  Cited 2024 Feb 25."},{"key":"1470_CR52","unstructured":"Z Creative Labs. React Simple Maps. React Simple Maps. 2022. Available from: https:\/\/www.react-simple-maps.io\/.  Cited 2025 Feb 17."},{"key":"1470_CR53","doi-asserted-by":"publisher","first-page":"e0010704","DOI":"10.1371\/journal.pntd.0010704","volume":"16","author":"C Ochieng","year":"2022","unstructured":"Ochieng C, Chen JC, Osita MP, Katz LS, Griswold T, Omballa V, et al. Molecular characterization of circulating Salmonella Typhi strains in an urban informal settlement in Kenya. Plos Neglect Trop D. 2022;16:e0010704.","journal-title":"Plos Neglect Trop D"},{"key":"1470_CR54","doi-asserted-by":"publisher","first-page":"100488","DOI":"10.1016\/j.lanwpc.2022.100488","volume":"24","author":"MR Davies","year":"2022","unstructured":"Davies MR, Duchene S, Valcanis M, Jenkins AP, Jenney A, Rosa V, et al. Genomic epidemiology of Salmonella Typhi in Central Division, Fiji, 2012 to 2016. Lancet Regional Heal - West Pac. 2022;24:100488.","journal-title":"Lancet Regional Heal - West Pac"},{"key":"1470_CR55","doi-asserted-by":"publisher","unstructured":"Dyson ZA, Ashton PM, Khanam F, Chunga A, Shakya M, Meiring J, et al. Genomic epidemiology and antimicrobial resistance transmission of Salmonella Typhi and Paratyphi A at three urban sites in Africa and Asia. medRxiv. 2023; 2023.03.11.23286741; https:\/\/doi.org\/10.1101\/2023.03.11.23286741","DOI":"10.1101\/2023.03.11.23286741"},{"key":"1470_CR56","doi-asserted-by":"publisher","first-page":"e567","DOI":"10.1016\/S2666-5247(22)00093-3","volume":"3","author":"KE da Silva","year":"2022","unstructured":"da Silva KE, Tanmoy AM, Pragasam AK, Iqbal J, Sajib MSI, Mutreja A, et al. The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study. Lancet Microbe. 2022;3:e567\u201377.","journal-title":"Lancet Microbe"},{"key":"1470_CR57","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4102\/ajlm.v7i2.924","volume":"7","author":"S Kariuki","year":"2018","unstructured":"Kariuki S, Keddy KH, Antonio M, Okeke IN. Antimicrobial resistance surveillance in Africa: successes, gaps and a roadmap for the future. Afr J Lab Med. 2018;7:924.","journal-title":"Afr J Lab Med"},{"key":"1470_CR58","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/jac\/dkq175","volume":"65","author":"Y Song","year":"2010","unstructured":"Song Y, Roumagnac P, Weill FX, Wain J, Dolecek C, Mazzoni CJ, et al. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A. J Antimicrob Chemother. 2010;65:1631\u201341.","journal-title":"J Antimicrob Chemother"},{"key":"1470_CR59","doi-asserted-by":"crossref","unstructured":"Thanh DP, Karkey A, Dongol S, Thi NH, Thompson CN, Rabaa MA, et al. A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure. eLife. 2016;5:e14003.","DOI":"10.7554\/eLife.14003"},{"key":"1470_CR60","doi-asserted-by":"publisher","first-page":"e0008036","DOI":"10.1371\/journal.pntd.0008036","volume":"14","author":"SIA Rahman","year":"2020","unstructured":"Rahman SIA, Dyson ZA, Klemm EJ, Khanam F, Holt KE, Chowdhury EK, et al. Population structure and antimicrobial resistance patterns of Salmonella Typhi isolates in urban Dhaka, Bangladesh from 2004 to 2016. PLoS Negl Trop Dis. 2020;14:e0008036.","journal-title":"PLoS Negl Trop Dis"},{"key":"1470_CR61","doi-asserted-by":"crossref","unstructured":"Tanmoy AM, Westeel E, Bruyne KD, Goris J, Rajoharison A, Sajib MSI, et al. Salmonella enterica Serovar Typhi in Bangladesh: Exploration of Genomic Diversity and Antimicrobial Resistance. mBio. 2018;9:e02112-18.","DOI":"10.1128\/mBio.02112-18"},{"key":"1470_CR62","first-page":"ciab897","volume":"74","author":"S Argim\u00f3n","year":"2021","unstructured":"Argim\u00f3n S, Nagaraj G, Shamanna V, Darmavaram S, Vasanth AK, Prasanna A, et al. Circulation of third-generation cephalosporin resistant Salmonella Typhi in Mumbai. India Clin Infect Dis. 2021;74:ciab897.","journal-title":"India. Clin Infect Dis"},{"key":"1470_CR63","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/microorganisms8091336","volume":"8","author":"F Rasheed","year":"2020","unstructured":"Rasheed F, Saeed M, Alikhan N-F, Baker D, Khurshid M, Ainsworth EV, et al. Emergence of Resistance to Fluoroquinolones and Third-Generation Cephalosporins in Salmonella Typhi in Lahore. Pakistan Microorganisms. 2020;8:1336.","journal-title":"Pakistan Microorganisms"},{"key":"1470_CR64","doi-asserted-by":"publisher","first-page":"e00850","DOI":"10.1128\/genomeA.00850-17","volume":"5","author":"D Gul","year":"2017","unstructured":"Gul D, Potter RF, Riaz H, Ashraf ST, Wallace MA, Munir T, et al. Draft Genome Sequence of a Salmonella enterica Serovar Typhi Strain Resistant to Fourth-Generation Cephalosporin and Fluoroquinolone Antibiotics. Genome Announc. 2017;5:e00850-e917.","journal-title":"Genome Announc"},{"key":"1470_CR65","unstructured":"Public Health England. UK Public Health Resistance Alert: Salmonella Typhi resistant to third generation cephalosporins isolated in England from a traveller returning from Pakistan. Health Protection Report. 2017;11."},{"key":"1470_CR66","doi-asserted-by":"crossref","unstructured":"Eshaghi A, Zittermann S, Bharat A, Mulvey MR, Allen VG, Patel SN. Importation of Extensively Drug-Resistant Salmonella enterica Serovar Typhi Cases in Ontario, Canada. Antimicrob Agents Chemother. 2020;64.","DOI":"10.1128\/AAC.02581-19"},{"key":"1470_CR67","doi-asserted-by":"publisher","first-page":"101610","DOI":"10.1016\/j.tmaid.2020.101610","volume":"36","author":"C Chirico","year":"2020","unstructured":"Chirico C, Tomasoni LR, Corbellini S, Francesco MAD, Caruso A, Scaltriti E, et al. The first Italian case of XDR Salmonella Typhi in a traveler returning from Pakistan, 2019: An alert for increased surveillance also in European countries? Travel Med Infect Dis. 2020;36:101610.","journal-title":"Travel Med Infect Dis"},{"key":"1470_CR68","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jmii.2020.03.017","volume":"54","author":"P-Y Liu","year":"2020","unstructured":"Liu P-Y, Wang K-C, Hong Y-P, Chen B-H, Shi Z-Y, Chiou C-S. The first imported case of extensively drug-resistant Salmonella enterica serotype Typhi Infection in Taiwan and the antimicrobial therapy. J Microbiol Immunol Infect. 2020;54:740\u20134.","journal-title":"J Microbiol Immunol Infect"},{"key":"1470_CR69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijregi.2021.10.011","volume":"1","author":"A Al-Rashdi","year":"2021","unstructured":"Al-Rashdi A, Kumar R, Al-Bulushi M, Abri SA, Al-Jardani A. Genomic analysis of the first cases of extensively drug-resistant, travel-related Salmonella enterica serovar Typhi in Oman. Ijid Regions. 2021;1:135\u201341.","journal-title":"Ijid Regions"},{"key":"1470_CR70","doi-asserted-by":"publisher","first-page":"254","DOI":"10.46234\/ccdcw2022.062","volume":"4","author":"Y Wang","year":"2022","unstructured":"Wang Y, Lu D, Jin Y, Wang H, Lyu B, Zhang X, et al. Extensively Drug-Resistant (XDR) Salmonella Typhi Outbreak by Waterborne Infection \u2014 Beijing Municipality, China, January\u2013February 2022. China Cdc Wkly. 2022;4:254\u20138.","journal-title":"China Cdc Wkly"},{"key":"1470_CR71","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1093\/cid\/ciaa1773","volume":"72","author":"ME Carey","year":"2021","unstructured":"Carey ME, Jain R, Yousuf M, Maes M, Dyson ZA, Thu TNH, et al. Spontaneous Emergence of Azithromycin Resistance in Independent Lineages of Salmonella Typhi in Northern India. Clin Infect Dis. 2021;72:e120\u20137.","journal-title":"Clin Infect Dis"},{"key":"1470_CR72","doi-asserted-by":"crossref","unstructured":"Sajib MSI, Tanmoy AM, Hooda Y, Rahman H, Andrews JR, Garrett DO, et al. Tracking the Emergence of Azithromycin Resistance in Multiple Genotypes of Typhoidal Salmonella. mBio. 2021;12: e03481-20.","DOI":"10.1128\/mBio.03481-20"},{"key":"1470_CR73","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jac\/dkx379","volume":"73","author":"MR Day","year":"2017","unstructured":"Day MR, Doumith M, Nascimento VD, Nair S, Ashton PM, Jenkins C, et al. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi. J Antimicrob Chemoth. 2017;73:365\u201372.","journal-title":"J Antimicrob Chemoth"},{"key":"1470_CR74","doi-asserted-by":"publisher","first-page":"e0003748","DOI":"10.1371\/journal.pntd.0003748","volume":"9","author":"NA Feasey","year":"2015","unstructured":"Feasey NA, Gaskell K, Wong V, Msefula C, Selemani G, Kumwenda S, et al. Rapid emergence of multidrug resistant, H58-lineage Salmonella typhi in Blantyre. Malawi PLoS Negl Trop Dis. 2015;9:e0003748.","journal-title":"Malawi PLoS Negl Trop Dis"},{"key":"1470_CR75","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/S2666-5247(23)00327-0","volume":"5","author":"PM Ashton","year":"2024","unstructured":"Ashton PM, Chirambo AC, Meiring JE, Patel PD, Mbewe M, Silungwe N, et al. Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study. Lancet Microbe. 2024;5:e226\u201334.","journal-title":"Lancet Microbe"},{"key":"1470_CR76","unstructured":"World Health Organization. International Pathogen Surveillance Network (IPSN).. Available from: https:\/\/www.who.int\/initiatives\/international-pathogen-surveillance-network.  Cited 2024 Feb 25."},{"key":"1470_CR77","unstructured":"World Health Organization. Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022\u20132032. Geneva: World Health Organization; 2022. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240046979"},{"key":"1470_CR78","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1016\/S1473-3099(20)30939-7","volume":"21","author":"SC Inzaule","year":"2021","unstructured":"Inzaule SC, Tessema SK, Kebede Y, Ouma AEO, Nkengasong JN. Genomic-informed pathogen surveillance in Africa: opportunities and challenges. Lancet Infect Dis. 2021;21:e281\u20139.","journal-title":"Lancet Infect Dis"},{"key":"1470_CR79","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1089\/fpd.2021.0110","volume":"19","author":"T Davedow","year":"2022","unstructured":"Davedow T, Carleton H, Kubota K, Palm D, Schroeder M, Gerner-Smidt P, et al. PulseNet International survey on the implementation of whole genome sequencing in low and middle-income countries for foodborne disease surveillance. Foodborne Pathog Dis. 2022;19:332\u201340.","journal-title":"Foodborne Pathog Dis"},{"key":"1470_CR80","doi-asserted-by":"publisher","first-page":"755","DOI":"10.4315\/JFP-21-437","volume":"85","author":"EL Stevens","year":"2022","unstructured":"Stevens EL, Carleton HA, Beal J, Tillman GE, Lindsey RL, Lauer AC, et al. Use of whole genome sequencing by the federal interagency collaboration for genomics for food and feed safety in the United States. J Food Protect. 2022;85:755\u201372.","journal-title":"J Food Protect"},{"key":"1470_CR81","unstructured":"Holt KE. AMRnet. 2023. Available from: https:\/\/www.lshtm.ac.uk\/research\/centres-projects-groups\/amrnet.  Cited 2023 Jul 2."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01470-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-025-01470-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01470-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:05:55Z","timestamp":1746767155000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-025-01470-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1186\/s13073-025-01470-4","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as the project concerns only data which are already in the public domain (please see Availability of data and materials), and no personal or clinical information relating to the bacterial isolates is included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KLC has received consultancy payments from Pfizer, travel support from BD, and is a member of the Society for Infectious Disease (Singapore). Robert SH was a chair for a Phase I\/II\/III studies to determine efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID- 19) vaccine ChAdOx1 nCoV- 19, and a chair for a Phase 1 Clinical Study to Determine the Safety and Immunogenicity of a Novel GMMA Vaccine Against Invasive Non-Typhoid Salmonella. Robert SH is also an executive board member of the International Society of Infectious Diseases, a member of the Infection & Immunity Board for the MRC\/UKRI, and a member of the NIHR Global Health Research Professorships Committee. MML was a co-developer of a Trivalent Salmonella (Enteritidis\/Typhimurium\/Typhi Vi) conjugate vaccine with Bharat Biotech International and the Wellcome Trust. MML has also received payments from Pfizer for consultancy work. MML holds US patents for \u201cCompositions and Methods for Producing Bacterial Conjugate Vaccines\u201d. MML was a member of a NIH DSMB that oversaw US government-funded efficacy trials of COVID- 19 vaccines. DSMB was disbanded after several vaccines were given Emergency Use Authorization. MML was a member of the Vaccines and Related Biological Products Advisory Committee of the FDA. CAM holds a patent for Salmonella conjugate vaccines and was an employee of Novartis Vaccines Institute for Global Health. INO has received payments from the Wellcome Trust for consultancy work (review panel member). INO receives royalties for books or book chapters published via Springer, Cornell University Press, and Oxford University Press. INO has received travel support from BMGF, ESCMID, and the American ASM. INFO has held leadership or advisory roles for Wellcome SEDRIC, the BMGF surveillance advisory group, the Thomas Bassir Biomedical Foundation, and International Centre for Antimicrobial Resistance Solutions (ICARS) Technical Advisory Forum. INO has also been the surveillance lead for the AMR Technical Work Group, Nigeria Center for Disease Control, the commissioner for The Lancet Commission for Nigeria, a scientific advisor for The Lancet Infectious Diseases, a senior editor for Microbial Genomics, and the editor in chief of the African Journal of Laboratory Medicine. AJP has been involved an Oxford University partnership with AZ for development of COVI19 vaccines. AJP has received payments for consultancy work from Shionogi. AJP is chair of DHSC\u2019s Joint Committee on Vaccination and Immunisation, and was a member of WHOs SAGE. MAC received support for travel from UKHSA, HEE and NIHR. JAC received support from BMGF, US NIH, and the WHO. NAF holds an NIHR Global Health Professorship. ARG received support from BMGF. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}